This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pierre Fabre Medicament. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Alexandre Gil: Innovator in Pharmaceutical Chemistry
Introduction
Alexandre Gil is a notable inventor based in La Primaube, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative medicinal compounds. His work focuses on addressing critical health issues, such as dyslipidemiae.
Latest Patents
Gil holds a patent for "Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae." This invention specifically involves dodecylthio-phenylacetanilide derivative complexes, including (S)-2',3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide and related derivatives, in combination with cyclodextrins. This innovative approach aims to enhance the efficacy of treatments for dyslipidemiae.
Career Highlights
Alexandre Gil is associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical industry. His role there has allowed him to focus on research and development, contributing to advancements in medical treatments. His dedication to innovation has positioned him as a key figure in his field.
Collaborations
Gil has collaborated with esteemed colleagues, including Joël Bougáret and Elie Leverd. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
In summary, Alexandre Gil is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly impact the treatment of dyslipidemiae. His innovative approach and collaborations with other experts highlight his commitment to advancing medical science.